CIBC Private Wealth Group’s ARK Genomic Revolution ETF ARKG Stock Holding History

CIBC Private Wealth Group’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$2.03K	Buy	70 +13	+23%	+$390	﹤0.01%	2797
2025 Q3	$1.58K	Sell	57 -32	-36%	-$809	﹤0.01%	2762
2025 Q2	$2.18K	Sell	89 -65	-42%	-$1.42K	﹤0.01%	2623
2025 Q1	$2.82K	Sell	154 -103	-40%	-$2.59K	﹤0.01%	2611
2024 Q4	$6.56K	Hold	257	–	–	﹤0.01%	2396
2024 Q3	$6.57K	Hold	257	–	–	﹤0.01%	2522
2024 Q2	$6.04K	Sell	257 -1,550	-86%	-$39.1K	﹤0.01%	2459
2024 Q1	$51.2K	Buy	+1,807	New	+$54.3K	﹤0.01%	1671
2023 Q4	–	Sell	-28,225	Closed	-$786K	–	1146
2023 Q3	$786K	Buy	+28,225	New	+$923K	﹤0.01%	654

Other funds holding ARKG

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

CIBC Private Wealth Group's ARKG Position: Q4 2025 in Review

CIBC Private Wealth Group increased its ARK Genomic Revolution ETF (ARKG) stake by 23% in Q4 2025, buying an estimated $390 and bringing the position to 70 shares worth $2.03K. The position accounts for ﹤0.01% of the portfolio, ranked #2797.

CIBC Private Wealth Group first reported a position in ARKG in Q3 2023 and has held it in 9 quarters since. The position peaked at $786K in Q3 2023. 238 funds tracked by Wall St. Rank hold ARKG as of Q4 2025.

CIBC Private Wealth Group held 70 shares of ARK Genomic Revolution ETF worth $2.03K as of Q4 2025.
CIBC Private Wealth Group bought 13 ARK Genomic Revolution ETF shares in Q4 2025, an estimated $390.
ARK Genomic Revolution ETF made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #2797 holding.
CIBC Private Wealth Group first reported a position in ARK Genomic Revolution ETF in Q3 2023 and has held it in 9 quarters since.
CIBC Private Wealth Group's ARK Genomic Revolution ETF position peaked at $786K in Q3 2023.
238 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.